Inactive Instrument
Lotus Pharmaceuticals, Inc. Stock Other OTC
Stocks
LTUS
US5457152032
Pharmaceuticals
OTC Markets Traded
| Market Cap | 9.74M 8.4M 7.72M 7.27M 13.66M 919M 13.77M 91.51M 35.63M 451M 36.54M 35.76M 1.56B | P/E 2009 |
3.88x | P/E 2010 | 4.84x |
|---|---|---|---|---|---|
| Enterprise Value | 14.38M 12.41M 11.41M 10.74M 20.18M 1.36B 20.35M 135M 52.63M 666M 53.98M 52.83M 2.3B | EV / Sales 2009 |
1.02x | EV / Sales 2010 | 0.95x |
| Free-Float |
99% | Yield 2009 * |
-
| Yield 2010 | - |
| 1 day | +41.51% |
| Manager | Title | Age | Since |
|---|---|---|---|
Georgene Rivers
CEO | Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Georgene Rivers
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +41.51% | -18.92% | - | - | 9.12M | |
| +1.09% | +2.33% | +8.02% | +83.51% | 45.7B | |
| +1.37% | +4.53% | +49.21% | +94.95% | 34B | |
| -1.63% | -1.87% | -11.54% | +34.27% | 11.73B | |
| -1.60% | -4.00% | +8.93% | +92.61% | 11.48B | |
| +1.54% | +3.12% | +39.68% | +130.57% | 9.28B | |
| -0.92% | -0.34% | +17.53% | +40.48% | 7.21B | |
| +1.29% | +2.43% | +45.56% | -17.21% | 6.62B | |
| -0.93% | -3.30% | +26.92% | +232.57% | 6.44B | |
| -0.63% | -4.16% | -44.00% | -7.82% | 5.01B | |
| Average | +4.12% | -0.04% | +15.59% | +75.99% | 15.27B | |
| Weighted average by Cap. | +0.52% | +0.50% | +20.05% | +82.62% |
| 2009 | 2010 | |
|---|---|---|
| Net sales | 57.82M 49.89M 45.86M 43.17M 81.12M 5.46B 81.8M 544M 212M 2.68B 217M 212M 9.27B | 72.7M 62.72M 57.66M 54.27M 102M 6.86B 103M 683M 266M 3.37B 273M 267M 11.65B |
| Net income | 16.43M 14.18M 13.03M 12.27M 23.05M 1.55B 23.25M 154M 60.13M 761M 61.67M 60.36M 2.63B | 14.42M 12.44M 11.44M 10.77M 20.24M 1.36B 20.41M 136M 52.79M 668M 54.14M 52.98M 2.31B |
| Net Debt | 5.29 4.57 4.2 3.95 7.43 499.6 7.49 49.76 19.37 245.2 19.87 19.44 848.24 | 4.65 4.01 3.69 3.47 6.52 438.53 6.57 43.68 17 215.22 17.44 17.07 744.55 |
Employees
-
Sector
Pharmaceuticals
